RedHill Biopharma (RDHL) Enterprise Value (2013 - 2026)
RedHill Biopharma's Enterprise Value was $7.39 million in the quarter ended Jun 30, 2026, down 97.8% from $338.08 million a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Enterprise Value (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, RedHill Biopharma's Enterprise Value was -$165.81 million through Jun 30, 2026; for the year ended Dec 31, 2025, it was $11.24 million, down 99.3% from the prior year.
- Enterprise Value shows a five-year compound annual growth rate of -87.1% (years ended Dec 2020 to Dec 2025).
- In earlier years, Enterprise Value was $1.6 billion in the year ended Dec 31, 2024 (-83.0%), $9.44 billion in the year ended Dec 31, 2023 (+9.2%), $8.64 billion in the year ended Dec 31, 2022 (-93.6%) and $135.89 billion in the year ended Dec 31, 2021 (-56.2%).
- The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Enterprise Value in data going back to the quarter ended Mar 31, 2013.
- The best year-over-year quarter for Enterprise Value over five years was the quarter ended Jun 30, 2024 (growth of 29.4%); the worst was the quarter ended Dec 31, 2025 (a decline of 99.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | RedHill Biopharma | 1.44 Mn | -15.18 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.47 Mn |
| Dec 31, 2025 | -717,049.84 |
| Jun 30, 2025 | -363,432.91 |
| Dec 31, 2024 | 3.39 Mn |
| Jun 30, 2024 | -4.87 Mn |
| Dec 31, 2023 | 3.89 Mn |
| Jun 30, 2023 | -5.14 Mn |
| Mar 31, 2023 | -11.24 Mn |
| Dec 31, 2022 | -11.30 Mn |
| Sep 30, 2022 | 11.24 Mn |
| Jun 30, 2022 | 18.85 Mn |
| Mar 31, 2022 | 103.92 Mn |
| Dec 31, 2021 | 106.45 Mn |
| Sep 30, 2021 | 152.61 Mn |
| Jun 30, 2021 | 212.36 Mn |
| Mar 31, 2021 | 205.10 Mn |
| Dec 31, 2020 | 280.96 Mn |
| Sep 30, 2020 | 334.26 Mn |
| Jun 30, 2020 | 214.04 Mn |
| Mar 31, 2020 | 78.16 Mn |
API Access
RedHill Biopharma Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();